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Abstract
Background: Splinting after contracture release for Dupuytren's disease of the hand is widely
advocated. The purpose of this systematic review was to evaluate the quantity and quality of
evidence regarding the effectiveness of splinting in the post-surgical management of Dupuytren's
contractures.
Methods: Studies were identified by searching the electronic databases Medline, AMED, CINAHL
and EMBASE. Studies were included if they met the following inclusion criteria: prospective or
retrospective, experimental, quasi-experimental or observational studies investigating the
effectiveness of static or dynamic splints worn day and/or night-time for at least 6 weeks after
surgery and reporting either individual joint or composite finger range of motion and/or hand
function. The methodological quality of the selected articles was independently assessed by the two
authors using the guidelines for evaluating the quality of intervention studies developed by
McDermid.
Results: Four studies, with sample sizes ranging from 23 to 268, met the inclusion criteria for the
systematic review. Designs included retrospective case review, prospective observational and one
controlled trial without randomisation. Interventions included dynamic and static splinting with a
mean follow-up ranging from 9 weeks to 2 years. Pooling of results was not possible due to the
heterogeneity of interventions (splint type, duration and wearing regimen) and the way outcomes
were reported.
Conclusion: There is empirical evidence to support the use of low load prolonged stretch through
splinting after hand surgery and trauma, however only a few studies have investigated this
specifically in Dupuytren's contracture. The low level evidence regarding the effect of post-
operative static and dynamic splints on final extension deficit in severe PIP joint contracture (>40°)
is equivocal, as is the effect of patient adherence on outcome. Whilst total active extension deficit
improved in some patients wearing a splint there were also deficits in composite finger flexion and
hand function. The lack of data on the magnitude of this effect makes it difficult to interpret whether
this is of clinical significance. There is a need for well designed controlled trials with proper
randomisation to evaluate the short-term and long-term effectiveness of splinting following
Dupuytren's surgery.
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Dupuytren's disease
Dupuytren's disease is a fibroproliferative disorder charac-
terized by the development of nodules and contractile
cords of the palmar fascia of the hand. Where the contrac-
tile cords cross the metacarpophalangeal (MCP) joint or
the proximal interphalangeal (PIP) joint contractures of
the digit into the palm occur. It is estimated that 20% of
men in the UK over the age of 60 have Dupuytren's dis-
ease[1]. Women are affected later in life but have a similar
prevalence to men in their eighth decade[2]. Treatment is
indicated when the contracted finger interferes with the
person's daily activities[3]. Surgical release of the con-
tracted digit with or without excision of the affected tissue
is the currently accepted intervention [1] with approxi-
mately 12,000 of these operations performed each year in
the UK[4].
Post-operative management
Hand therapy is advocated following Dupuytren's surgery
with the overall aim to improve hand function[5]. The
therapist uses a variety of techniques and modalities to
promote wound healing, manage scar tissue, maximise
finger extension and flexion and restore function[6].
Splinting is a commonly prescribed therapeutic modality
designed to maximise the finger extension achieved from
Dupuytren's surgery. Surveys of surgeons and therapists in
the UK have identified that between 55–98% of respond-
ents feel there is a role for splinting following Dupuytren's
surgery [7-9]. Although a majority use splinting, there is a
wide variation in how frequently it is applied. Salim [10]
found that 14% of surgeons surveyed splinted following
all operations, 19% usually splinted and 22% rarely did.
There is also wide variation regarding position, force and
duration of splinting[7,9]. Currently decisions regarding
the indications for splinting and the parameters of the
splint design and use are based on clinical experience and
surgeon preference due to a lack of high quality evi-
dence[6,8].
Rationale for splint use
Scar contracture is a recognized complication following
Dupuytren's surgery [11]. Prolonged low-load application
of force is advocated as the most effective way to positively
influence scar remodelling[12]. Controlling scar tissue
with prolonged low load tension can prevent contracture
of the MCP and PIP joints. Although exercises can deliver
a prolonged low-load force, splinting has been identified
as the most practical method to achieve the necessary time
application [12] especially when used overnight.
A persistent PIP joint contracture is a known complication
following Dupuytren's surgery[13]. Such contractures
may be due to capsular tightness following prolonged PIP
joint flexion from the Dupuytren's disease or due to com-
plications from the operation itself, for example oedema
restricting movement[4]. Splinting has been shown to be
an effective treatment for both chronic (greater than six
months duration) and acute (21 days to six months dura-
tion) PIP joint flexion contractures following PIP joint
soft tissue injuries[13,14]. The reasoning for using splints
after surgery for DD is that they provide a low-load con-
tinuous force which maintains the correction achieved
intra-operatively and prevent contracture recurrence. Such
splints are normally worn for 3 to 6 months as scar matu-
ration and therefore the splints' effect on remodelling
continues for this time period.
Rationale for not using splints
On the other hand splinting is not a benign modality.
Indiscriminate or inappropriate use of immobilization
through splinting may result in joint stiffness, prolonged
pain, oedema and subsequently reduced function[15].
Misapplication of force may also have unwanted effects
on soft tissue for example attenuation of ligaments result-
ing in joint instability or overgrowth of scar tissue in
response to increased stress[12]. It is also questionable
after in vitro studies showed that stress may have an accel-
erative effect on the fibroproliferative process in
Dupuytren's tissue[16]. From a practical perspective,
splinting is time consuming and potentially expensive for
the clinician. Patients may consider it inconvenient or
even a nuisance to wear a splint for prolonged periods.
The need for a systematic review investigating splinting 
following Duputyren's surgery
Surveys have highlighted the lack of consensus regarding
indications for and parameters of splinting following
Dupuytren's surgery and refer to the lack of good quality
evidence[7,8]. Based on clinical experience and evidence
extrapolated from other populations, many surgeons and
therapists feel it is prudent to use a splint following sur-
gery in some or all Dupuytren's patients. The purpose of
this article is to identify and appraise available evidence
regarding the effectiveness of splinting following
Dupuytren's surgery. Such reviews provide a useful syn-
thesis of evidence to date which may guide evidence-
based clinical decisions and highlight the need for further
primary research.
Methods
A systematic review of the literature was undertaken to
evaluate the quantity and quality of evidence regarding
the clinical effectiveness of post-operative splinting after
surgical release for DC in the hand.
Search strategy
The electronic bibliographic databases Medline, AMED,
CINAHL and EMBASE (from their inception to October
2007) were searched using the following terms:Page 2 of 7
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abstracts retrieved were read and assessed according to
inclusion criteria. Full text was obtained for those articles
which met the inclusion criteria or where it was impossi-
ble to assess these from the title and abstract. The refer-
ences for each study which met the inclusion criteria were
also scanned to identify any further studies not retrieved
through the initial search. Additionally the Journal of Hand
Surgery (British and European, and American Volumes),
Journal of Hand Therapy and British Journal of Hand Therapy
from 1990 to date were hand searched.
Inclusion criteria were:
• Prospective or retrospective, experimental, quasi-experi-
mental or observational studies investigating the effective-
ness of static or dynamic splints worn day and/or night-
time for at least 6 weeks after surgery
• Studies reporting at least one of the following outcomes:
individual joint or composite finger range of motion,
hand function
Exclusion criteria:
• Studies primarily designed to investigate the effective-
ness of different surgical techniques or approaches (for
example fasciectomy versus dermofasciectomy) where
splinting was used as part of the post-operative regimen
• Descriptive articles of splinting regimens and/or splint
design and construction
• Studies of pre-operative splinting
• Non-English language articles
Quality assessment
The focus of this systematic review was on the evaluation
of effectiveness of post-operative splinting therefore ran-
domised or non-randomised controlled trials needed to
be included. Study design could have been used as a selec-
tion criterion or used to set a quality threshold, however
the initial search highlighted a paucity of research and
only one of the studies retrieved would have met this cri-
terion. It was therefore decided to include the next best
available evidence in the hierarchy of evidence, that is,
observational studies and retrospective case series.
Each study was independently read and reviewed by both
authors and assessed for methodological quality using the
guidelines for evaluating the quality of intervention stud-
ies developed by McDermid[17]. It consists of 24 criteria
which are scored as 0, 1 or 2 giving a maximum score of
48 (see legend to additional file 1 for criteria).
The scores from each reviewers were tabulated and com-
pared. Where there was discrepancy the reviewers dis-
cussed the item until consensus on the score was reached.
Results
The initial search generated 33 references (excluding
duplicates) for which the titles and abstracts were read to
assess if they met inclusion criteria. 28 articles were
excluded and the remaining 5 articles were obtained as
full text and assessed by both authors. Jain et al's study
[18] was subsequently excluded as the splinting interven-
tion was less than 6 weeks leaving 4 studies available for
review (see Figure 1).
There were no prospective, randomised, controlled trials
and the 4 studies included one controlled trial without
randomisation[19], one prospective observational study
without control or comparator group[20], and one retro-
spective case review [21]. Evans et al's study [22] included
retrospective case review as well as prospective compari-
son of two groups. Sample sizes ranged from 20 to 268
patients. The interventions studied included dynamic
splinting, static splinting and the comparison of two posi-
tions in static splints. Mean follow up ranged from 9
weeks [22] to 2 years[20].
Tables provided in the additional files 2, 3, and 4 summa-
rise the main characteristics and findings of each study.
Quality assessment of studies
The final scores for each study using the MacDermid crite-
ria [17] are presented in the additional file 1. Final quality
scores for the 4 studies ranged from 17 to 22 points out of
a total of a possible score of 48 points.
The level of agreement between the two reviewers for all
four studies ranged from 54% to 66%. Any discrepancies
between the reviewers related mostly to the interpretation
of the criteria which once agreed resulted in consistent
grading and no third reviewer was required to resolve any
disagreements.
Discussion
The quality of evidence
The number of studies evaluating the effectiveness of post-
operative splinting is small and the quality of the evidence
is low. Two of the evaluation criteria were consistently not
met by any of the studies, these were lack of randomisa-
tion to groups (question 5) and lack of sample size calcu-
lation (question 11). The low scores also reflect a lack of
detail in proper reporting of results. Ebscov et al used pro-
portion of patients with contractures and Rives et al only
gave percentage improvement. No actual degrees of range
of motion were reported making it also difficult to inter-
pret the clinical significance. Glassey reported actualPage 3 of 7
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for self-reported hand function as measured by the Disa-
bilities of the Arm, Shoulder and Hand Questionnaire
(DASH[23]).
Splinting interventions and effectiveness
Two studies investigated the effect of dynamic
splinting[19,20]. Ebscov et al used a control group,
though allocation to groups was not randomised and
prone to allocation bias as only patients with rapidly
recurring contracture of 25° or more were given a splint.
This means that there are systematic differences between
the two groups in terms of contracture severity. Those
with recurrence are likely to have had a worse pre-op con-
tracture and also likely to have had incomplete correction
at surgery. Dias & Braybrooke [4] in an audit of Dupu-
tyren;s surgery found that recurrence of contracture was
higher in those with greater initial deformity. In Ebscov et
al's study the mean pre-operative contracture in the non-
splint group was 23 degrees and 49 degrees in the splint
group, respectively. The results at 9 months showed that a
greater proportion of patients 12/15 (80%) in the splint
group including those who met criteria for adequate wear
(> 3 months) had an increased contracture of the PIPJ of
10 – 40 or > 40 degrees (see table 1a) compared to the no
splint group (45%). Only 9/15 (60%) who were allocated
to wear a splint but did not met the criteria for adequate
wear had a PIP contracture of 10 – 40 or >40 degrees. It
can be assumed that these two groups are comparable as
they both had severe pre-op contractures of at least 25°
and were allocated to receive a splint, yet compliance with
the splint did not appear to benefit this group.
The study by Rives et al did not use a comparator group
and all patients were allocated to receive a splint. Inclu-
sion criteria were 'severe DC with PIPJ contracture ≥ 45°
but excluding those with recurrent disease'. All patients
were allocated to receive a splint however the results were
analysed by compliance. Wear for 50% of time or longer
was defined as compliant. The results from this group (n
= 20) was compared to those in the non-compliant group
(n = 7). Differences in percentage improvement of PIPJ
extension between the compliant and non-compliant
group were statistically significant at the 1, 3, 12 and 24
months follow-up (p < 0.05). Follow-up was the longest
in this study and whilst the authors report statistically sig-
nificant findings favouring the compliant group there is
no indication of the magnitude of effect making it difficult
to interpret the clinical significance of any differences.
Moreover functional outcome such as the effect of
reduced contracture on hand function was not measured.
Rives's study highlights the important effect which patient
compliance has on the efficacy of splints on final exten-
sion deficit, though this is contradicted by Ebscov's results
which showed that a greater proportion of patients who
had complied with splint wear had a recurrent contracture
of 10–40 or >40 degrees.
Two studies investigated the effect of static splints. Glassey
[21] conducted a retrospective review comparing the out-
flowchart of studies retrieved through search and inclusion/exclusion criteriaFigure 1
flowchart of studies retrieved through search and inclusion/exclusion criteria.
 
Title/abstract of potentially 
relevant studies identified and 
screened  (n=33) 
Full studies excluded (n=1) 
Reasons: 
post-op splinting  less than 6 weeks (n=1) Jain 
et al 1988 
Full text studies retrieved and 
reviewed  (n=5) 
Titles excluded (n=28) 
Reasons:  
pre-operative splinting (n=2) 
Incomplete study (n=1) 
Not research (n=14) 
Non-English language (n=5) 
Not splinting (n=6) 
Studies included in final review 
(n=4) Page 4 of 7
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splint (n = 21) worn for three months with those who had
not (n = 10). Patients with a pre-operative MCP contrac-
ture only were excluded from the study. Use of a splint
was determined by the surgeons' preference. Again bias is
a concern due to the lack of randomised allocation and
the small sample size. Baseline data indicated significant
differences in age and occupational status between the
groups. Other potential confounders such as severity of
pre-operative contracture and bilateral presentation were
not reported or included in the between group analysis.
These factors are known to increase the risk of a persistent
contracture [4,24] and would be known to the surgeon
potentially influencing the prescription of a splint. The
results at three months post-operatively found that func-
tion as assessed by the DASH and finger extension were
significantly better in the non-splint group. Actual mean
values and standard deviation for DASH scores were not
provided so it is impossible to know if the difference in
score is clinically meaningful or lies within the bounda-
ries of measurement error. The splint group lost an aver-
age of 4.76° extension whilst the non-splint group gained
an average of 13.75° (see additional file 3).
Evans et al [22] combined a retrospective case review with
a prospective observational study investigating the effects
of tension applied (TA) (n = 103) from splinting in the
first three weeks following Dupuytren's surgery versus no
tension applied (NTA) (n = 165). At three weeks, all
patients were treated with the same night extension splint.
All patients attending the clinic were included. The TA
group was retrospectively studied with the prospective
component investigating TA versus NTA. It is not
described how the groups are allocated in the prospective
component of the study but randomisation is not men-
tioned. The groups experienced similar outcomes in terms
of range of motion however the NTA group required fewer
therapy visits over a shorter period of time with fewer scar
and flare symptoms (see additional file 4). The scales used
to assess scar and flare have not been tested for reliability
and validity therefore introducing doubt as to their value.
The short follow-up period of five to ten weeks is also
insufficient to judge the long term effects of the interven-
tion as contractures can develop up to a year following a
Dupuytren's operation[20].
Outcomes assessed
All studies used MCPJ and or PIPJ range of motion (RoM)
as the primary outcome measure. There were also differ-
ences in the way RoM was reported with some only meas-
uring the degree of contracture or lack of MCP or PIPJ
extension. It could be argued that a splint may assist in
maintaining finger extension however anecdotal evidence
suggest that patients often complain that after a night of
wearing a splint they find it difficult to flex their digits or
make a fist. Only Glassey [21] included total active exten-
sion and total active flexion. In her retrospective case
review at 3 months patients without a splint had 20°
more total flexion than the splint group, although this dif-
ference was not statistically significant.
Whilst degree of operative correction and hence the
amount of joint extension is indisputably an important
outcome it only reflects change at the level of impairment.
Other outcomes including activities and participation
were only addressed in Glassey's study through the inclu-
sion of the DASH. Notably the DASH score in the non-
splint group was significantly better than in the splint
group, though actual mean DASH scores were not
reported for either group making it difficult to interpret
whether this difference was minimally clinically impor-
tant at ≥12 points[25].
Length of follow-up
The length of follow-up ranged from a few weeks to two
years. Three of the four studies [19-21] used the splint for
up to 6 months. It is debatable as to what is an appropri-
ate endpoint to evaluate the effectiveness of splinting
which also depends on what the primary outcome meas-
ure is. If recurrence of the contracture is the main criterion
than outcome may need to be assessed no earlier than 1
year. On the other hand the effect of night splinting on
loss of full composite finger flexion and hand function is
likely to manifest itself sooner and possibly only during
the period during which the splint is worn, that is up to 6
months, justifying a shorter follow-up period of 3 or 6
months.
Limitations
Limiting this review to English language publications only
may have lead to the exclusion of good quality studies,
though the initial screening of titles and abstracts did not
identify any RCTs in foreign language journals. The small
number and heterogeneity of studies as well as the low
methodological quality has limited the synthesis of find-
ings and conclusions which can be drawn.
Conclusion
This review identified only 4 studies providing low level
evidence on the effects of static and dynamic post-opera-
tive splinting. None of the studies allocated patients to
interventions randomly and therefore systematic differ-
ences between groups are likely to have biased results. The
quality of the reporting was poor and due to the heteroge-
neity in splint types, duration of wear, outcomes and fol-
low-up period it was not possible to pool the results.
Whilst one study indicates that splinting results in fewer
contractures especially when patients are compliant with
wearing a splint another study did not support this,
favouring the group who did not meet criteria for ade-Page 5 of 7
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shorter (9 months). Although improved finger extension
is undoubtedly an important outcome of long-term night
splinting, composite finger flexion and hand function are
also important parameters of the effect of splinting. Only
one study included these as outcomes and the results indi-
cate that patients allocated to wear a splint had lower total
finger flexion and higher DASH scores (greater disability)
at 3 months. These 'negative' effects may well disappear at
6 month or 1 year but no study to date has examined this.
Whilst the value of splints in delivering a low-load pro-
longed stretch to healing tissues after hand trauma and
hand surgery has been well argued its effect on the dis-
eased fascia in DD even after surgical excision remains
unknown. Post-operative splinting is widely used and like
many interventions in hand rehabilitation supported only
by clinical reasoning and anecdotal evidence. The clinical
effectiveness of long-term static night splinting on finger
movement and hand function remains unproven and a
properly randomized controlled trial is needed with a suf-
ficient sample size to confer adequate power for detecting
clinically important differences. The effect of different
types of splints, duration and patient adherence need to
be factored into future trials. Further work is also needed
to establish the most appropriate primary and secondary
outcomes and follow-up time in future studies of effec-
tiveness.
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